Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Abingdon Health Plc

Healthcare GB ABDX

7.8GBX
0.55(7.59%)

Last update at 2026-03-10T15:40:00Z

Day Range

7.007.99
LowHigh

52 Week Range

5.108.50
LowHigh

Fundamentals

  • Previous Close 7.25
  • Market Cap17.50M
  • Volume291507
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.86600M
  • Revenue TTM8.43M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 3.74M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -3.80500M -1.39900M -3.55600M -21.59300M -6.95400M
Minority interest - - - - -
Net income -3.41500M -1.27100M -3.45100M -21.26200M -6.97300M
Selling general administrative 7.71M 5.07M 5.22M 6.64M 7.55M
Selling and marketing expenses - 0.05M - - -
Gross profit 3.13M 3.68M 2.08M -3.59200M 4.14M
Reconciled depreciation 0.61M 0.43M 0.76M 8.83M 0.75M
Ebit -3.73000M -1.34200M -3.50500M -11.86100M -5.37200M
Ebitda -3.12200M -0.91600M -2.74600M -3.03200M -4.62300M
Depreciation and amortization 0.61M 0.43M 0.76M 8.83M 0.75M
Non operating income net other - - - - -
Operating income -4.02500M -1.37300M -3.57300M -21.52800M -6.72000M
Other operating expenses 12.45M 7.51M 7.64M 14.70M 16.99M
Interest expense 0.07M 0.06M 0.07M 0.07M 0.23M
Tax provision -0.08100M -0.12800M -0.10500M -0.33100M 0.02M
Interest income 0.10M 0.03M 0.09M 0.00400M 0.23M
Net interest income 0.01M -0.02600M 0.02M -0.06500M -0.23400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.39000M -0.12800M -0.10500M -0.33100M 0.02M
Total revenue 8.43M 6.13M 4.04M 2.83M 11.62M
Total operating expenses 7.15M 5.05M 5.67M 8.27M 9.52M
Cost of revenue 5.30M 2.46M 1.97M 6.43M 7.47M
Total other income expense net 0.22M -0.02600M 0.02M -9.72800M -1.58158M
Discontinued operations - - - - -
Net income from continuing ops -3.41500M -1.27100M -3.45100M -21.26200M -6.97300M
Net income applicable to common shares - - -3.45100M -21.26200M -6.97300M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 9.31M 5.09M 6.06M 12.77M 33.23M
Intangible assets 0.50M 0.15M 0.09M 0.04M 0.47M
Earning assets - - - - -
Other current assets - 0.58M - 1.35M 0.97M
Total liab 4.01M 2.84M 3.05M 6.34M 11.90M
Total stockholder equity 5.30M 2.25M 3.01M 6.43M 21.33M
Deferred long term liab - - - - 0.39M
Other current liab 1.59M 1.00M 0.23M -0.36700M -0.36700M
Common stock 0.09M 0.03M 0.03M 0.03M 0.02M
Capital stock 0.05M 0.03M 0.03M 0.03M 0.02M
Retained earnings -32.17300M -28.76000M -27.45600M -24.10600M -2.96600M
Other liab - - - - -
Good will 2.28M 0.38M 0.00000M 0.76M 0.76M
Other assets - 0.00000M - - 0.39M
Cash 1.92M 1.44M 3.24M 2.40M 4.98M
Cash and equivalents - - - - -
Total current liabilities 2.92M 1.82M 2.12M 5.32M 10.76M
Current deferred revenue - 0.40M - 0.37M 0.37M
Net debt -0.89000M -0.39100M -2.21700M -1.11700M -3.48200M
Short term debt 0.26M 0.12M 0.09M 0.27M 0.35M
Short long term debt 0.09M 0.00000M 0.00000M 0.12M 0.12M
Short long term debt total 1.03M 1.05M 1.02M 1.28M 1.50M
Other stockholder equity 37.04M 30.81M 30.43M 30.51M 24.27M
Property plant equipment - - 1.21M 1.78M 9.04M
Total current assets 5.13M 3.55M 4.76M 10.96M 22.96M
Long term investments - - - - -
Net tangible assets - - 2.92M 6.40M 20.10M
Short term investments - - - - -
Net receivables 2.69M 1.08M 1.15M 6.68M 9.12M
Long term debt 0.65M 0.72M 0.71M 0.43M 0.37M
Inventory 0.53M 0.44M 0.33M 0.53M 7.89M
Accounts payable 0.77M 0.60M 2.03M 5.06M 10.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.34M 0.17M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.01M - - -6.69500M
Deferred long term asset charges - - - - -
Non current assets total 4.18M 1.54M 1.30M 1.81M 10.27M
Capital lease obligations 0.28M 0.33M 0.31M 0.73M 1.00M
Long term debt total - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -1.42700M -0.02300M -0.06800M -0.75600M -7.27500M
Change to liabilities - - -3.18000M -5.17000M 0.00000M
Total cashflows from investing activities -1.42700M -0.02300M -0.06800M -0.75600M -7.27500M
Net borrowings - 0.00000M -0.00600M -0.10200M 0.03M
Total cash from financing activities 5.08M -0.11400M -0.00700M 5.92M 20.74M
Change to operating activities - - - - -
Net income -3.41500M -1.27100M -3.45100M -21.26200M -6.97300M
Change in cash 0.48M -1.79600M 0.84M -2.58000M 0.59M
Begin period cash flow 1.44M 3.24M 2.40M 4.98M 4.39M
End period cash flow 1.92M 1.44M 3.24M 2.40M 4.98M
Total cash from operating activities -3.18200M -1.65900M 0.91M -7.73900M -12.87600M
Issuance of capital stock 5.63M 0.00000M 0.00000M 6.14M 20.70M
Depreciation 0.61M 0.43M 0.76M 8.83M 0.75M
Other cashflows from investing activities 0.10M 0.03M 0.09M 0.00400M -0.44300M
Dividends paid - - - - -
Change to inventory -0.08500M -0.11200M 0.20M 2.32M -7.10900M
Change to account receivables -0.62400M -0.29700M 6.65M 2.13M -1.07000M
Sale purchase of stock - - - - 20.70M
Other cashflows from financing activities -0.17100M -0.11400M 0.11M -0.09600M 0.06M
Change to netincome - - 0.02M 17.24M 1.53M
Capital expenditures 0.33M 0.04M 0.16M 0.76M 7.25M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.54200M -0.74400M 3.67M -0.71400M -8.17900M
Stock based compensation 0.21M 0.05M 0.03M 0.23M 1.37M
Other non cash items -0.04700M -0.11800M -0.26900M -0.17500M 0.09M
Free cash flow -3.43200M -1.70000M 0.76M -8.49900M -20.12700M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ABDX
Abingdon Health Plc		 0.55 7.59% 7.80 - 67.57 2.08 3.20 1.91 -0.2499
IDHC
Integrated Diagnostics Holdings PLC		 -0.0001 0.02% 0.59 0.18 12.89 0.0006 2.89 0.06 0.21
DXRX
Diaceutics PLC		 - -% 145.00 - 19.72 3.52 1.85 2.71 17.28
CLBX
CelLBxHealth plc		 0.10 11.11% 1.00 - - 7.00 1.67 6.81 -1.6211
VRCI
Verici Dx Plc		 0.007 1.22% 0.58 - - 851.60 3.00 637.86 -1.1703

Reports Covered

Stock Research & News

View All

Profile

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

Abingdon Health Plc

York Biotech Campus, York, United Kingdom, YO41 1LZ

Key Executives

Name Title Year Born
Mr. Chris Henry Francis Yates CEO & Director 1974
Ms. Melanie Ross CFO, Company Sec. & Director 1980
Mr. Mark Jones Chief Operating Officer NA
Ms. Brenda Hogan HR Director NA
Mr. Oliver Gardner Chief Commercial Officer NA
Ms. Nina Garrett Head of Assay Devel. NA
Dr. Christopher William Hand Executive Chairman 1961
Mr. Thomas Edward Hayes Secretary, CFO & Director 1976
Mr. Chris Henry Francis Yates President of & Director Abingdon Health USA Inc. 1974
Ms. Nina Garrett Chief Technical Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.